Vaccine makers in India have a limited stockpile of doses, even as COVID-19 threatens to rear its head this winter season, reports Sohini Das. IMAGE: A beneficiary is being inoculated with a......
The prevalent strain of COVID-19 is mild and the Serum Institute of India has already produced five to six million doses of the Covovax vaccine, said the company's chief executive officer Adar......
IMAGE: Adar Poonawalla, CEO, Serum Institute of India. Photograph: ANI Photo With only 146 sites conducting vaccinations in India and a few hundred vaccine shots administered every day,......
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of Covid-19 vaccine Covishield amid rising numbers of cases of the virus infection. IMAGE:......
In view of rising cases of COVID-19 in various parts of the country, Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute's Covovax on the CoWIN......
SBI was the top loser in the Sensex pack, shedding over 1 per cent. ITC, NTPC, Tech Mahindra, Tata Steel, Kotak Bank and M&M were among major losers. Benchmark indices Sensex and Nifty retreated......
As many as 28 of its constituents closed with gains while two declined. The broad-based Nifty of the National Stock Exchange rose by 147.20 points or 0.86 per cent to settle 17,233.45, tracking......